Perioperative Blood Loss Management in Total Joint Arthroplasty

Abstract

<p>Minimizing blood loss in total joint arthroplasty (TJA) involves multiple interdisciplinary approaches and has experienced significant evolution over the last decade. TJA often requires post-operative blood transfusion, conferring significant risks upon TJA patients. Minimizing these risks by limiting blood loss has garnered recent interest. Variable strategies have been developed to manage perioperative bleeding, such as autologous donation, electrocautery, hemodilution, blood salvage systems, tourniquets, controlled hypotension, lower transfusion triggers, erythropoietic stimulating agents, and antifibrinolytics. This study reviews current blood loss reduction techniques and underscores the importance of antifibrinolytics and their impact on transfusion reduction. </p>